- Home
- SONM vs BOLT Comparison
SONM vs BOLT Comparison
Compare SONM & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONM
- BOLT
- Stock Information
- Founded
- SONM 1999
- BOLT 2015
- Country
- SONM United States
- BOLT United States
- Employees
- SONM N/A
- BOLT N/A
- Industry
- SONM Telecommunications Equipment
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- SONM Telecommunications
- BOLT Health Care
- Exchange
- SONM Nasdaq
- BOLT Nasdaq
- Market Cap
- SONM 12.1M
- BOLT 11.5M
- IPO Year
- SONM 2019
- BOLT 2021
- Fundamental
- Price
- SONM $11.22
- BOLT $5.86
- Analyst Decision
- SONM
- BOLT Buy
- Analyst Count
- SONM 0
- BOLT 4
- Target Price
- SONM N/A
- BOLT $34.00
- AVG Volume (30 Days)
- SONM 58.6K
- BOLT 37.7K
- Earning Date
- SONM 11-12-2025
- BOLT 11-14-2025
- Dividend Yield
- SONM N/A
- BOLT N/A
- EPS Growth
- SONM N/A
- BOLT N/A
- EPS
- SONM N/A
- BOLT N/A
- Revenue
- SONM $57,917,000.00
- BOLT $4,167,000.00
- Revenue This Year
- SONM $127.68
- BOLT N/A
- Revenue Next Year
- SONM N/A
- BOLT N/A
- P/E Ratio
- SONM N/A
- BOLT N/A
- Revenue Growth
- SONM N/A
- BOLT N/A
- 52 Week Low
- SONM $9.38
- BOLT $4.59
- 52 Week High
- SONM $114.84
- BOLT $13.80
- Technical
- Relative Strength Index (RSI)
- SONM 96.04
- BOLT 52.16
- Support Level
- SONM $0.66
- BOLT $5.65
- Resistance Level
- SONM $12.30
- BOLT $6.35
- Average True Range (ATR)
- SONM 0.31
- BOLT 0.33
- MACD
- SONM 1.24
- BOLT -0.02
- Stochastic Oscillator
- SONM 90.71
- BOLT 35.21
About SONM Sonim Technologies Inc.
Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.